Endocrinology and metabolism (memo from NEJM Knowledge plus and MKSAP)
・Tx for acute episode of diabetic neuropathy
glucose control, low-dose tricycle antidepressant (desipramine), capsaicin cream
・mechanism of hypercalcemia due to disseminated tuberculosis
macrophages in tuberculous granuloma activate vitamin D
・diagnosis of diabetes by HbA1c
> 6.5% in separate occasion
・outcome of laser photocoagulation for diabetic retionpathy
diminished peripheral and night vision with retention of central vision
・evaluation of secondary amenorrhea with normal labs work-up
progesterone challenge test (evaluate whether estrogen is low or normal)
・management of bilateral adrenal hyperplasia
conservative management with spironolactone
・Tx for myxedema coma
thyroid hormone and stress-dose glucocorticoid until excluding concurrent adrenal insufficiency
・maturity-onset diabetes of the young
diagnosed in adolescence, deteriorate slowly, strong family history
・monophilament test for diabetic neuropathy
plantar surface of distal hallux and 1st, 3rd, 5th metatarsal head of each foot
・Tx of Graves disease ophthalmopathy in the setting of intolerance to anti-thyroid Tx
trial of prednisone, thyroidectomy
・indication of parathyroidectomy for primary hyperparathyroidism
symptomatic hypercalcemia (nephrolithiasis, arrhythmia), or regardless of Sx with GFR<60, or T score <-2.5, or fragility fracture, or < 50 yo
・gynecomastia in male
imbalance in testosterone-to-estrogen ratio -> check serum levels
・euthyroid sick syndrome
TSH no more than 10
・hormone deficiency after traumatic brain injury
GH
・Tx for large papirally thryoid cancer (> 4cm)
surgery followed by radioactive iodine therapy
・sudden discontinuation of megestrol for anorexia
cause adrenal insufficiency due to its glucocorticoid activity
・indication of surgery for primary hyperparathyroidism
Ca > 1mg/dl + upper limit, GFR < 60, osteoporosis, fracture
・next management for patient with Sx of thyrotoxicosis, significantly elevated T3, TSH of 1.5
pituitary MRI to evalute TSH-secreting pituitary tumor (TSH usually not detectable in primary thyroid disorder)
・next step for patient with persistently elevated ALP (bone isoform), bone scan showing uptake in multiple bones
plain radiograph of bones to diagnose Paget disease (osteitis deformans)
・elevated testosterone in female
from ovary or adrenal gland
adrenal gland produce dehydroepiandrosterone sulfate (DHEAS)
・Tx for macroprolactinoma
first line: dopamine agonist
surgery only when failure of medical management or visual deterioration
・Somogyi phenomenon
(hypoglycemia during night leads to rebound hyperglycemia in the morning)
this theoretical concept has been disproven as a cause of fasting hyperglycemia
・Dawn phenomenon
elevation in glucose during the morning (4AM-8AM) result from physiolosic release of cortisol and GH
・adverse effect of chronic opioid use
central hypogonadism -> low libido, erectile dysfunction
・central adrenocorticotropic hormone deficiency during pregnancy
lymphocytic hypophysitis (rare autoimmune disorder)
・benign familial hypocalciuric hypercalcemia
high-normal PTH level and family history
・above what of random cortisol level make diagnosis of adrenal insufficiency unlikely in critically ill patients
12
・evaluation of male hypogonadism
measure of morning total testosterone level (not free testosterone)
・Tx for hirsutism from polycystic ovary syndrome
oral contraceptive which decrease testosterone production by ovary
・management of abdominal pain in the setting of DKA (general tenderness, leukocytosis, AMY 1000)
serial abdominal exam
・suggestive finding of malignant adrenal incidentaloma
> 4cm, attenuation > 20
・management of amiodarone-induced thyrotoxicosis
prednisone and beta blocker
鎮静・鎮痛 (ICU)
<鎮痛>
Mild pain (pain score 1-3)
- Fentanyl 25mcg IV q2h prn
- Hydromorphone 0.25mg IV q4h prn
- Morphine 2mg IV q2h prn
- Ketorolac 15mg IV q6h prn
Moderate pain (pain score 4-6)
- Fentanyl 50mcg IV q2h prn
- Hydromorphone 0.5mg IV q4h prn
- Morphine 4mg IV q2h prn
- Ketorolac 15mg IV q6h sch
Severe pain (pain score 7-10)
- Fentanyl 75mcg IV q2h prn
- Hydromorphone 1mg IV q4h prn
- Morphine 6mg IV q2h prn
[Continuous infusion for analgesia]
Fentanyl 2500mcg/NS 200ml
Start at 25 mcg/hr; titrate by 10 mcg/hr q5 min to PAIN Score 3/10; or to GOAL RASS Score 0 to -1; to a maximum of 200 mcg/hr
(Adjust in opioid tolerant patients. No max when used for comfort measures)
Morphine 100mg/NS 90ml
Start at 1 mg/hr; titrate by 1mg/hr q5min to PAIN Score 3/10; or to GOAL RASS Score 0 to -1; to a maximum of 20 mg/hr.
(Adjust in opioid tolerant patients. No max when used for comfort measures)
Hydromorphone 50mg/NS 50ml
Start at 0.2 mg/hr; titrate by 0.2 mg/hr q30 min to Pain Score 3/10
or GOAL RASS Score 0 to -1; to a maximum of 2 mg/hr
(No max when used for comfort measures)
<鎮静>
Propofol 1000mg/100ml
Start at 5 mcg/kg/min; titrate by 5 mcg/kg/min q 10 min
to GOAL RASS Score 0 to -1; to a maximum of 70 mcg/kg/min
Dexmedetomidine 200mcg/NS 50ml
Loading dose of 1 mcg/kg over 10 min
THEN Start at 0.2 mcg/kg/hr; titrate by 0.1 mcg/kg/hr q30 min to GOAL RASS Score 0 to -1; to a maximum 1.4 mcg/kg/hr as tolerated.
Midazolam 100mg/NS 80ml
Start at 1 mg/hr titrate by 1 mg/hr q5 min to GOAL RASS Score 0 to -1; to a maximum of 10 mg/hr
[Neuromuscular blocker]
Cisatracurium 200mg/NS 200ml
Loading dose 0.15 mg/kg = [ ]mg
Start at 3 mcg/kg/min; titrate by 0.5 mcg/kg/min q 20 min
to a maximum of 10 mcg/kg/min to a train of four (TOF)
of at least 1-2/4 to maintain ventilator synchrony
<Delirium>
- Quetiapine 25mg PO q8h sch
- Haloperidol lactate 2mg IV q8h sch
(HOLD if QTC greater than 25% increase from baseline QTC or absolute corrected QT of 0.48)
- Dexmedetomidine iv (the same protocol above)
(dexmedetomidine is the sedation medication of choice in hemodynamically stable patient with significant delirium)
(米国一施設基準)
ICU持続静脈注射薬
Amiodarone
[bolus]
amiodarone 150mg in 100ml D5W at 618ml/hr iv x 1
[continuous]
amiodarone/D5W 750mg/500ml
Start at 1 mg/min x 6 hours, then 0.5 mg/min
Maximum rate 1.5 mg/min
Diltiazem
diltiazem/NS 100mg/100ml
Loading dose 0.25mg/kg over 2 min
Start at 5 mg/hr
titrate by 5 mg/hr q10 min
Titrate to Goal Ventricular Rate <100
Hold for HR<50 or SBP <90
to a maximum of 15 mg/hr
(Usual range 5 mg/hr to 15 mg/hr)
Dobutamine
dobutamine/D5W 250mg/250ml
Start at 2 mcg/kg/min
titrate by 2 mcg/kg/min every 5 min
Titrate to Goal parameter:
to a maximum of 20 mcg/kg/min
(Usual range 1 mcg/kg/min to 20 mcg/kg/min)
Dopamine
dopamine/D5W 400mg/250ml
Start at 2 mcg/kg/min
Titrate by 1 mcg/kg/min every 5 min
To a Goal MAP > or = 65 mmHg to a maximum of 25 mcg/kg/min
(Usual range 1 mcg/kg/min to 25 mcg/kg/min)
Epinephrine
epinephrine 1mg/NS250ml
Start at 0.01 mcg/kg/min
Titrate by 0.01 mcg/kg/min every 5 min
To a maximum of 1 mcg/kg/min or MAP > 65 mmHg
(Usual range 0.01 mcg/kg/min to 1 mcg/kg/min)
Esmolol
esmolol/NS 2500mg/250ml
Start at 50 mcg/kg/min
titrate by 50 mcg/kg/min q5 min
Titrate to Goal to keep HR <100
Hold for HR <50 or SBP <90
to a maximum of 300 mcg/kg/min
(Usual range 50 mcg/kg/min to 300 mcg/kg/min)
Furosemide
furosemide 1000mg/100ml
Start at 5 mg/hr
titrate by 5 mg/hr q60 min
Titrate to Goal Urine Output 0.5 ml/kg/hr
to a maximum of 40 mg/hr
(Usual range 5 mg/hr to 40 mg/hr)
Isoproterenol
isoproterenol/D5W 1mg/250ml
Start at 0.01 mcg/kg/min
titrate by 0.01 mcg/kg/min every 5 min
Titrate to Goal parameters:
to a maximum of 0.4 mcg/kg/min
(Usual range 0.01mcg/kg/min to 0.4 mcg/kg/min)
Labetalol
labetalol/NS 200mg/200ml
Loading dose 10 mg IV
Start at 2 mg/min
titrate by 1 mg/min every 5 min
Titrate to Goal SBP [ ] mmHg
Hold for HR <50
to a maximum of 8 mg/min
(Usual range 2 mg/min to 8 mg/min)
Lidocaine
lidocaine/D5W 2000mg/250ml
Start at 14 mcg/kg/min
titrate by 7 mcg/kg/min
Titrate to eliminate Ventricular Tachycardia
to a maximum of 57 mcg/kg/min
(Usual range 14 mcg/kg/min to 57 mcg/kg/min)
Milrinone
milrinone/D5W 20mg/100ml
Loading dose 50 mcg/kg over 10 min
Start at 0.375 mcg/kg/min
titrate by 0.05 mcg/kg/min q30 min
Titrate to Goal parameter:
to a maximum of 0.75 mcg/kg/min
(Usual range 0.375 mcg/kg/min to 0.75 mcg/kg/min)
Nicardipine
nicardipine/NS 20mg/200ml
Start at 5 mg/hr
titrate by 2.5 mg/hr every 5 min
Titrate to Goal SBP [ ] mmHg
Hold for HR <50
to a maximum of 15 mg/hr
(Usual range 5 mg/hr to 15 mg/hr)
Nitroglycerin
nitroglycerin/D5W 100mg/250ml
Start at 0.1 mcg/kg/min
titrate by 0.2 mcg/kg/min q3 min
Titrate to eliminate chest pain
Maintain SBP > 100 mmHg
to a maximum of 5 mcg/kg/min
(Usual range 0.1 mcg/kg/min to 5 mcg/kg/min)
Nitroprusside
nitroprusside/NS 100mg/250ml
Start at 0.5 mcg/kg/min
titrate by 0.5 mcg/kg/min every 2 min
Titrate to Goal SBP [ ] mmHg
to a maximum of 10 mcg/kg/min
(Usual range 0.5mcg/kg/min to 10mcg/kg/min)
Norepinephrine
norepinephrine/NS 8mg/250ml
Start at 0.01 mcg/kg/min
Titrate by 0.02 mcg/kg/min every 5 min
To a Goal MAP > or = 65 mmHg to a maximum of 3 mcg/kg/min
(Usual range 0.01 mcg/kg/min to 3 mcg/kg/min)
Phenylephrine
phenylephrine/NS 50mg/250ml
Start at 0.3 mcg/kg/min
Titrate by 0.1 mcg/kg/min every 5 min
To a Goal MAP > or = 65 mmHg to a maximum of 10 mcg/kg/min
(Usual range 0.3 mcg/kg/min to 10 mcg/kg/min)
Procainamide
procaineamide/NS 1000mg/250ml
Start at 1 mg/min;
titrate by 1mg/min q 20 min
Titrate to Goal parameter:
to a maximum of 6mg/min up to 24 hr
(Usual range 1 mg/min to 6 mg/min)
Vasopressin
vasopressin/NS 50units/250ml
Start at 0.01 units/min
Goal MAP > or = 65 mmHg
(Usual range 0.01 units/min to 0.04 units/min)
(米国一施設基準)
疼痛コントロール
This order set is based on the WHO Analgesic Ladder
Directions:
1. Assess pain severity
2. Begin treatment at the appropriate step of the Ladder
3. If starting at Step 2 or 3 ensure the all appropriate medications from Step 1 are administered in addition to the current step
4. Progress through the steps until pain is controlled
STEP 1
- Acetaminophen 650mg PO Q4H PRN for mild pain
plus celebrex (with higher risk of bleeding)
- Celecoxib 200mg PO Q12H SCH
or ketorolac (with lower risk of bleeding)
- Ketorolac 15mg IV Q6H SCH
(maximum dose of 120mg/day for 5 days. avoid in renal dysfunction, GI bleeding, Platelet abnormality, concomitant administration of ACEI, CHF, cirrhosis, asthma)
Mild pain (pain score 1-3)
- oxycodone IR 5mg PO Q4H PRN
- oxycodone oral solution (5mg/5ml 5mg) 5mg PO Q4H PRN
STEP 2
Moderate pain (pain score 4-6)
(hydromorphone or oxycodone preferred option)
- Hydromorphone 2mg PO Q4H PRN
- Oxycodone IR 10mg PO Q4H PRN
- Oxycodone oral solution (5mg/5ml 5mg) 10mg PO Q4H PRN
- Morphine IR 15mg PO Q4H PRN
Unable to take PO
- Hydromorphone 0.5mg IV Q3H PRN
- Morphine 2mg IV Q3H PRN
STEP 3
Severe pain (pain score 7-10)
(hydromorphone preferred option)
- Hydromorphone 4mg PO Q4H PRN
- Morphine 30mg PO Q4H PRN
Unable to take PO
- Hydromorphone 0.5mg IV Q2H PRN
- Morphine 4mg IV Q3H PRN
(米国一施設基準)
譫妄
検査
- Fingerstick Glucose
- Urine drug screen
- UA + Culture
- CBC/CMP
- Digoxin level PRN
- ABG
- EKG
- Chest portable X-ray
コンサルテーション
- psychiatry consult
- speech language consult
Medication
All Medications should be used only when non-pharmacologic interventions have failed and caution should be used when dosing these medications in the elderly
Caution:
* If QTc>450ms, highly recommend to discuss treatment options with psychiatry prior to ordering any medications below
* Please observe for the following: extrapyramidal symptoms
* If differential diagnosis is alcohol withdrawal or benzodiazepine withdrawal, initiate CIWA protocol
For hyperactive delirium with agitation, confusion, restlessness, sleep disturbance x 24 hours
- Haloperidol 0.5/1mg PO Q2H PRN for hyperactive delirium
(total IV or PO maximum: not to exceed 10mg/24hours)
- Risperidone 0.5mg PO BID PRN for hyperactive delirium
- Quetiapine 12.5mg PO Q6H PRN for hyperactive delirium
For hyperactive delirium with combative behavior, spitting, throwing x 24 hours
- Haloperidol 2mg IV Q2H PRN for hyperactive delirium
(total IV or PO maximum: not to exceed 10mg/24hours)
- Risperidone 1mg PO BID PRN for hyperactive delirium
- Quetiapine 25mg PO Q6H PRN for hyperactive delirium
(米国一施設基準)
End of Life Comfort Care
Nurse order
Provide private room
Visitor okay pre-post normal hours
食事
Regular diet(持ち込み可)
コンサルテーション
Pain management consult
Social service consult
Spiritual care consult
疼痛コントロール
- Morphine (20mg/1ml solution) 10/20mg sublingual Q1H PRN for pain
- Morphine 1/2/4mg IV Q1H PRN for pain
- Morphine IV (100mg/NS100cc) 持続
start at 1mg/hr, titrate by 1mg/hr every 5 minutes, maximum dose: none
- Hydromorphone 0.2/0.4mg IV Q4H PRN for severe pain
- Hydromorphone IV (50mg/NS50cc) 持続
start at 0.2mg/hr, titrate to patient comfort
- Fentanyl Patch 12/25/50/75/100mcg/hr Q3D SCH
- Acetaminophen 650mg PO Q4H PRN
- Acetaminophen 650mg PO Q6H SCH
掻痒時
- Diphenhydramine 25mg PO Q4H PRN for pruritis
- Diphenhydramine 25mg IV Q4H PRN for pruritis
便秘時
- Senna-Docusate 2 tab PO HS PRN for constipation
- Bisacodyl Suppository 10mg PR DAILY PRN for constipation
口腔内分泌過多時
- Scopolamine 1.5mg/72hr Patch 1 patch TD Q72H PRN for excess secretions
- Hyoscyamine 0.125mg PO Q4H PRN for excess secretions
不安時
- Lorazepam 1mg PO Q4H PRN for agitation
- Lorazepam 1mg IV Q2H PRN for agitation
不眠時
- Haloperidol 1mg PO HS PRN for sleep
嘔気時
- Prochlorperazne 10mg PO Q6H PRN for nausea/vomiting
- Ondansetron 4mg IV Q6H PRN for nausea/vomiting
- Prochlorperazine 25mg PR Q12H PRN for nausea/vomiting
(米国一施設基準)
Insulin Sliding Scale
インスリンスライディングスケール
Low dose protocol (インスリン1日量が40単位以下の患者)
70-100 no insulin
101-150 no insulin
151-199 1単位/no insulin
200-249 2単位/no insulin
250-299 3単位/1単位
300-349 4単位/2単位
350以上 5単位 call MD/2単位 call MD
(insulin aspart:食前/眠前)
Medium dose protocol (インスリン1日量が40-80単位の患者)
70-100 no insulin
101-150 no insulin
151-199 2単位/no insulin
200-249 4単位/no insulin
250-299 6単位/3単位
300-349 8単位/4単位
350以上 10単位 call MD/5単位 call MD
(insulin aspart:食前/眠前)
High dose protocol (インスリン1日量が80単位以上の患者)
70-100 no insulin
101-150 no insulin
151-199 3単位/no insulin
200-249 6単位/no insulin
250-299 9単位/4単位
300-349 12単位/6単位
350以上 15単位 call MD/7単位 call MD
(insulin aspart:食前/眠前)
絶食・TPN投与時
血糖測定6時間ごと
インスリン:insulin regular
投与量は食事摂取時と同じ
眠前投与量の変更なし
低血糖プロトコール
経口可能時
軽度~中等度 (40-69mg/dl) グルコース15 gram 経口
重度(40mg/dl以下) グルコース30 gram 経口
経口不能、IV accessある時
軽度~中等度 (40-69mg/dl) 50%ブドウ糖液12.5 gram IV
重度(40mg/dl以下) 50%ブドウ糖液25 gram IV
IV accessなしかつ経口不能
グルカゴン 1mg IM, 続いてグルコース経口投与あるいは5%ブドウ糖液100m/hrで開始
インスリン持続静脈投与(not for DKA)
Insulin regular 100units/NS100cc
Goal: Fingerstick blood glucose 110-150mg/dl
Initiate IV Insulin Infusion
(Bolus/Infusion)
< 150 No bolus / No infusion
150-180 2 units / 1 unit/h
181-210 3 units / 2 units/h
211-250 4 units / 4 units/h
251-300 5 units / 6 units/h
> 300 call MD
Further titration
Fingerstick blood glucose check every 1 hour
(Bolus/Infusion)
< 70 hypoglycemic protocol
<110 No bolus / stop infusion
110-150 No bolus / no change
151-180 No bolus / increase by 1 unit/h
181-210 2 units / increase by 2 units/h
211-250 3 units / increase by 3 units/h
251-300 5 units / increase by 4 units/h
301-400 8 units / increase by 5 units/h
>400 call MD
If FSBG decrease >40mg/dl regardless of range, decrease rate by 50%
If FSBG decrease 2 consecutive readings in 110-150 range, decrease rate by 50%
(米国一施設基準)